RMC-5127
RMC-5127-001
Phase 1 small_molecule active
Quick answer
RMC-5127 for Non-small Cell Lung Cancer (NSCLC) is a Phase 1 program (small_molecule) at Revolution Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Revolution Medicines
- Indication
- Non-small Cell Lung Cancer (NSCLC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active